Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 6/20 | 0.81 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.81 |
| ▸ | F3 | P13726 | 1/20 | 0.81 |
| ▸ | PNLIP | P16233 | 1/20 | 0.81 |
| ▸ | NOS2 | P35228 | 1/20 | 0.81 |
| ▸ | CES2 | O00748 | 2/20 | 0.72 |
| ▸ | CES1 | P23141 | 2/20 | 0.72 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.65 |
| ▸ | STAT3 | P40763 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.63 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.63 |
| ▸ | RELA | Q04206 | 1/20 | 0.63 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.63 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.63 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.63 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16152971 | 1.00 | PTPN1 (0.81) | PTPN1PTPN2F3PNLIPNOS2 | |
| SCHEMBL18687848 | 1.00 | PTPN1 (0.81) | PTPN1PTPN2F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL18688313 | 0.89 | PTPN2 (1.00) | PTPN1PTPN2F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL2762433 | 0.89 | PTPN2 (1.00) | PTPN1PTPN2F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL12337276 | 0.89 | PTPN2 (1.00) | PTPN1PTPN2F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL6898284 | 0.89 | PTPN2 (1.00) | PTPN1PTPN2F3PNLIPNOS2 | |
| SCHEMBL17166004 | 0.89 | PTPN1 (0.85) | PTPN1PTPN2F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL18687844 | 0.89 | PTPN2 (1.00) | PTPN1PTPN2F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL12200334 | 0.89 | PTPN2 (1.00) | PTPN1PTPN2F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL12313105 | 0.89 | PTPN2 (1.00) | PTPN1PTPN2F3PNLIPNOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250169516-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-05-29 | — | — | US | disclosed |
| US-12239142-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-03-04 | — | — | US | disclosed |
| US-20240376435-A1 | KIDNEY ORGANOID AND METHOD FOR PRODUCING SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-11-14 | — | — | US | disclosed |
| US-20240268402-A1 | Methods, Devices and Compositions for Preserving Human Milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2024-08-15 | — | — | US | disclosed |
| EP-4397749-A1 | KIDNEY ORGANOID AND METHOD FOR PRODUCING SAME | Otsuka Pharmaceutical Co., Ltd. (JP) | 2024-07-10 | — | — | EP | disclosed |
| WO-2023033137-A1 | KIDNEY ORGANOID AND METHOD FOR PRODUCING SAME | 大塚製薬株式会社 | 2023-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | PTPN1 4634/4885PTPN2 4668/4885F3 1704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.